JUSTINE RICE: Open Payments
NPI 1740709773 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,906 in 143 payments from 20 companies in 2025. Trend: 2023 $2,208 · 2024 $2,425 · 2025 $2,906
Food & beverage: $2,807Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $583 |
| United Therapeutics Corporation | 14 | $305 |
| GlaxoSmithKline, LLC. | 24 | $282 |
| Grifols USA, LLC | 10 | $231 |
| Verona Pharma, Inc. | 11 | $196 |
| Actelion Pharmaceuticals US, Inc. | 6 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $182 |
| Merck Sharp & Dohme LLC | 7 | $170 |
| GENZYME CORPORATION | 9 | $164 |
| ANI Pharmaceuticals, Inc. | 7 | $139 |
Products named: DUPIXENT, BREZTRI, Prolastin-C Liquid, Tyvaso, Ohtuvayre, FASENRA, TRELEGY ELLIPTA, PURIFIED CORTROPHIN GEL.
Industry payments across MS — which companies pay providers there.
